Most providers (20/21; 95%) initiate therapy for pubertal induction when patients are between ages 14 and 17 years, whereas one provider reported starting patients before 14 years of age. Of the 4 patients in the hCG group, 3 were being managed by Urology and only one by Endocrinology. Of the remaining 46 patients whose charts lacked documentation of such a discussion, 10 patients had grade 1 disability and 36 patients had no or grade 0 disability. We had a total of 42 patients with grade 0 disability and 10 patients with grade 1 disability.
Young boys also can have too much testosterone if they touch testosterone gel that an adult man is using for treatment High testosteroneWhen young boys have too much testosterone, they can start puberty too early (before age 9). Some things can temporarily lower testosterone, for instance, too much exercise, poor nutrition, or serious illness. Later, low testosterone can lead to decreased muscle and bone strength, less energy, and lower fertility. Ask your doctor if you should get your testosterone level checked if you have any of the problems mentioned below. When this hormone is not in balance, health problems can result.
The regimens used to treat men with HH usually consist of hCG 1,500–2,000 IU 2–3 times weekly to achieve at testosterone level within the normal range. While less prevalent, the impact of hCG therapy is just as great, as these men were once deemed infertile and now can regain spermatogenesis with hCG therapy. Figure 1 contains a summary of recommendations for initiating spermatogenesis in men using AAS or TRT (16). If the next SA at three months has persistent azoospermia, then testicular sperm extraction (TESE)/micro TESE should be considered. For these men hCG based treatments have been used to induce spermatogenesis sooner.
Interventional studies in humans will be the only way to demonstrate direct causality between gonadotropin receptors and the abovementioned effects. Functional FSHRs were found in endometriotic lesions, where FSH may induce CYP19A1 expression and estrogen production249. However, results concerning the existence of FSHR–LHCGR transactivation were also provided, although stably transfected HEK293 cells used in this study were not a physiological model237. It is reasonable that GPCRs interact with molecules having an overall similar structure, as previously demonstrated for receptors of other pituitary225 and non-pituitary226 hormones. The activation of cAMP is due to the preferential coupling to the Gs protein when FSHR is maximally expressed215,223 in granulosa cells at the early/mid-antral stage of the menstrual cycle. On the other hand, steroids activate anti-apoptotic signals172,219, as obligatory regulators of folliculogenesis220, even inducing multi-follicular maturation during assisted reproduction221,222, where relatively high gonadotropin doses are administered.
These hormones are regulated by the hypothalamic–pituitary–gonad (HPG) axis, which is either quiescent or activated at different stages of the life course, and the regulation of the axis is crucial for the development and normal function of the male reproductive system. Male fertility hinges on the availability of testosterone, a cornerstone of spermatogenesis, while follicle-stimulating hormone (FSH) signaling is indispensable for the proliferation, differentiation, and proper functioning of Sertoli and germ cells. The αERKO mouse model showed slight increases in serum gonadotropin and testosterone levels, degeneration of the seminiferous tubules affecting spermatozoa production, including fertilizing capacity. The role of the HPG axis and the endocrine system in the control of both spermatogenesis and testosterone production in males is well-known. Estrogens control many physiological processes in mammals, including reproduction, spermatogenesis, ovulation, granulosa-cell proliferation, reproductive tract development, breast development, cardiovascular health, and bone integrity.
Acknowledging and addressing the challenges in reproducing these signals is critical for advancing our capabilities in fertility restoration and for deepening our understanding of the elaborate interplay of physiological systems involved in sperm production. Hormonal regulation within this process is notably challenging to dissect due to the interconnected nature of the endocrine system, where hormones often interact with or influence other testis-acting hormones in largely synergistic ways. This complexity is not unique to reproductive biology; for instance, the in vivo intestinal stem cell compartment also illustrates the challenges in capturing physiological interactions within tissues . Although research began decades ago, our understanding of male hormone regulation is continually evolving with new discoveries. 7α-methyl-19- nortestosterone (MENT, an androgenic–anabolic steroid) has been proven to be more effective in inhibiting pituitary gonadotropin than testosterone and the potential of its subcutaneous implants is being investigated 198,199. Therefore, there is a need for the development of new male hormonal contraceptives that are convenient, effective, reversible, and affordable. Developing new contraceptives for men is challenging, and interfering with spermatogenesis through hormonal approaches is a hot topic of research.

Gender: Female

Social links